Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma

Gemcitabine has high activity against nasopharyngeal carcinoma (NPC). The level of ribonucleotide reductase subunit M1 (RRM1) expression is closely related to the efficacy of gemcitabine on non-small cell lung cancer and pancreatic cancer. However, the expression of RRM1 and its association with sen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Li-Ping, Xue, Cong, Zhang, Jian-Wei, Hu, Zhi-Huang, Zhao, Yuan-Yuan, Zhang, Jing, Huang, Yan, Zhao, Hong-Yun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777452/
https://www.ncbi.nlm.nih.gov/pubmed/22692073
http://dx.doi.org/10.5732/cjc.012.10029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777452/
https://www.ncbi.nlm.nih.gov/pubmed/22692073
http://dx.doi.org/10.5732/cjc.012.10029

Ejemplares similares